211 related articles for article (PubMed ID: 31675377)
1. Integrative proteomic and phosphoproteomic profiling of prostate cell lines.
Katsogiannou M; Boyer JB; Valdeolivas A; Remy E; Calzone L; Audebert S; Rocchi P; Camoin L; Baudot A
PLoS One; 2019; 14(11):e0224148. PubMed ID: 31675377
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.
Saraon P; Cretu D; Musrap N; Karagiannis GS; Batruch I; Drabovich AP; van der Kwast T; Mizokami A; Morrissey C; Jarvi K; Diamandis EP
Mol Cell Proteomics; 2013 Jun; 12(6):1589-601. PubMed ID: 23443136
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.
Saraon P; Musrap N; Cretu D; Karagiannis GS; Batruch I; Smith C; Drabovich AP; Trudel D; van der Kwast T; Morrissey C; Jarvi KA; Diamandis EP
J Biol Chem; 2012 Oct; 287(41):34019-31. PubMed ID: 22908226
[TBL] [Abstract][Full Text] [Related]
4. Quantitative phosphoproteomics reveals the protein tyrosine kinase Pyk2 as a central effector of olfactory receptor signaling in prostate cancer cells.
Wiese H; Gelis L; Wiese S; Reichenbach C; Jovancevic N; Osterloh M; Meyer HE; Neuhaus EM; Hatt HH; Radziwill G; Warscheid B
Biochim Biophys Acta; 2015 Jun; 1854(6):632-40. PubMed ID: 25219547
[TBL] [Abstract][Full Text] [Related]
5. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Comparison and MRM-Based Comparative Analysis of Metabolites Reveal Metabolic Shift in Human Prostate Cancer Cell Lines.
Shu Q; Cai T; Chen X; Zhu HH; Xue P; Zhu N; Xie Z; Wei S; Zhang Q; Niu L; Gao WQ; Yang F
J Proteome Res; 2015 Aug; 14(8):3390-402. PubMed ID: 26147661
[TBL] [Abstract][Full Text] [Related]
7. Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2009 Dec; 22(6):1451-8. PubMed ID: 19885599
[TBL] [Abstract][Full Text] [Related]
8. Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.
Endoh K; Nishi M; Ishiguro H; Uemura H; Miyagi Y; Aoki I; Hirano H; Kubota Y; Ryo A
Prostate; 2012 May; 72(6):626-37. PubMed ID: 21809350
[TBL] [Abstract][Full Text] [Related]
9. Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.
Myers JS; Vallega KA; White J; Yu K; Yates CC; Sang QA
BMC Cancer; 2017 Jul; 17(1):480. PubMed ID: 28697756
[TBL] [Abstract][Full Text] [Related]
10. Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression.
Tonry C; Armstrong J; Pennington SR
Oncotarget; 2017 Feb; 8(9):14374-14394. PubMed ID: 28086232
[TBL] [Abstract][Full Text] [Related]
11. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of protein profiling by proteomic analysis in camptothecin-resistant PC3 and camptothecin-sensitive LNCaP human prostate cancer cells.
Hasegawa N; Mizutani K; Suzuki T; Deguchi T; Nozawa Y
Urol Int; 2006; 77(4):347-54. PubMed ID: 17135786
[TBL] [Abstract][Full Text] [Related]
13. The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines.
O'Connell K; Prencipe M; O'Neill A; Corcoran C; Rani S; Henry M; Dowling P; Meleady P; O'Driscoll L; Watson W; O'Connor R
Proteomics; 2012 Jul; 12(13):2115-26. PubMed ID: 22623417
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
15. From Androgen Dependence to Independence in Prostate Cancer: Unraveling Therapeutic Potential and Proteomic Landscape of Hydroxychloroquine as an Autophagy Inhibitor.
Yanar S; Bal Albayrak MG; Kasap M; Akpinar G
OMICS; 2024 May; 28(5):246-255. PubMed ID: 38722704
[TBL] [Abstract][Full Text] [Related]
16. Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics.
Kwon OK; Jeon JM; Sung E; Na AY; Kim SJ; Lee S
Cancer Genomics Proteomics; 2018; 15(4):279-290. PubMed ID: 29976633
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity proteomics of prostate cancer tissue microarrays to discriminate between healthy and cancerous tissue.
Turiák L; Ozohanics O; Tóth G; Ács A; Révész Á; Vékey K; Telekes A; Drahos L
J Proteomics; 2019 Apr; 197():82-91. PubMed ID: 30439472
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of human prostate cancer.
Ahram M; Best CJ; Flaig MJ; Gillespie JW; Leiva IM; Chuaqui RF; Zhou G; Shu H; Duray PH; Linehan WM; Raffeld M; Ornstein DK; Zhao Y; Petricoin EF; Emmert-Buck MR
Mol Carcinog; 2002 Jan; 33(1):9-15. PubMed ID: 11807953
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
Bennett NC; Hooper JD; Johnson DW; Gobe GC
Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]